Overview

Influenza Vaccine in Lung Transplant Patients - Persistence of Antibodies

Status:
Completed
Trial end date:
2009-07-01
Target enrollment:
0
Participant gender:
All
Summary
This a sub-study of a 5-year study designed to investigate how antibody and T cell responses following influenza vaccine compare among lung transplant patients, patients waiting for lung transplantation, and healthy individuals. This study is designed to investigate influenza vaccine-induced antibodies in lung transplant patients between seasons.
Accepts Healthy Volunteers?
Accepts Healthy Volunteers
Details
Lead Sponsor:
University of Wisconsin, Madison
Criteria
Inclusion Criteria:

- Receiving care pre- or post-lung transplant at University of Wisconsin Hospital

- Healthy adult

Exclusion Criteria:

- Allergy to eggs

- Moderate to severe febrile illness

- Active treatment for acute rejection

- Received season's influenza vaccine prior to enrollment